The significance of incidental noncardiac findings in Tc-99m sestamibi myocardial perfusion imaging: illustrated by a case.
AUTOR(ES)
Chatziioannou, S N
RESUMO
Technetium 99m sestamibi is widely used in the evaluation of myocardial perfusion imaging. Although the aim of such imaging is cardiac evaluation, numerous other organs are included in the imaging field. Failure to identify incidental abnormal findings in these organs delays diagnosis and treatment. In common with other radiopharmaceutical agents, technetium 99m sestamibi is distributed throughout the body and accumulates in multiple tissues. When interpreting studies that involve this radiotracer, the physician must be aware of its physiologic distribution, in order to recognize abnormal uptake. We present an illustrative case in which areas of decreased tracer activity were noted incidentally during the evaluation of unprocessed single photon emission computed tomography data. These findings were due to metastasis of colon cancer to the liver.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=325648Documentos Relacionados
- Clinical significance of transient left ventricular dilation assessed during myocardial Tc-99m sestamibi scintigraphy
- Novel Tc-99m radiotracers for brain imaging
- Technetium Tc 99m sestamibi for parathyroid imaging.
- Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans.
- Cintilografia miocárdica de perfusão com Tc-99m sestamibi em pacientes com forma crônica indeterminada da doença de Chagas